These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23814582)

  • 21. Primary treatment of pediatric plunging ranula with nonsurgical sclerotherapy using OK-432 (Picibanil).
    Roh JL; Kim HS
    Int J Pediatr Otorhinolaryngol; 2008 Sep; 72(9):1405-10. PubMed ID: 18617276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of lymphangiomas arising around cervico-facial region: surgery, bleomycin therapy and OK-432 therapy].
    Ogita S; Tsuto T; Deguchi E; Tokiwa K; Yanagihara J; Iwai N
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1389-91. PubMed ID: 2479816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerosing treatment of lymphangiomas with OK-432.
    Luzzatto C; Midrio P; Tchaprassian Z; Guglielmi M
    Arch Dis Child; 2000 Apr; 82(4):316-8. PubMed ID: 10735841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of ranula wth intracystic injection of the streptococcal preparation OK-432.
    Fukase S; Ohta N; Inamura K; Aoyagi M
    Ann Otol Rhinol Laryngol; 2003 Mar; 112(3):214-20. PubMed ID: 12656411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sclerotherapy with OK-432 for cystic tumors in the neck region].
    Bloching M; Götze G; Passmann M; Neumann K
    HNO; 2005 Mar; 53(3):238-42. PubMed ID: 15221083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children.
    Ogita S; Tsuto T; Tokiwa K; Takahashi T
    Br J Surg; 1987 Aug; 74(8):690-1. PubMed ID: 3651773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature.
    Poldervaart MT; Breugem CC; Speleman L; Pasmans S
    J Craniofac Surg; 2009 Jul; 20(4):1159-62. PubMed ID: 19553857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts.
    Kim MG; Kim SG; Lee JH; Eun YG; Yeo SG
    Laryngoscope; 2008 Dec; 118(12):2177-81. PubMed ID: 19029851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations.
    Ono S; Iwai N; Chiba F; Furukawa T; Fumino S
    J Pediatr Surg; 2010 Sep; 45(9):e7-10. PubMed ID: 20850615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OK-432 and lymphatic malformations in children: the Starship Children's Hospital experience.
    Wheeler JS; Morreau P; Mahadevan M; Pease P
    ANZ J Surg; 2004 Oct; 74(10):855-8. PubMed ID: 15456432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
    Olsnes C; Stavang H; Brokstad K; Olofsson J; Aarstad HJ
    BMC Immunol; 2009 Jan; 10():6. PubMed ID: 19175917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response.
    Närkiö-Mäkelä M; Mäkelä T; Saarinen P; Salminen P; Julkunen I; Pitkäranta A
    Eur Arch Otorhinolaryngol; 2011 Jan; 268(1):123-9. PubMed ID: 20635092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult cystic hygroma: successful use of OK-432 (Picibanil).
    Woolley SL; Smith DR; Quine S
    J Laryngol Otol; 2008 Nov; 122(11):1260-4. PubMed ID: 18430261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of lymphangiomas with picibanil in the first year of life].
    Subotic U; Hosie S; Waag KL; Reinshagen K
    Klin Padiatr; 2008; 220(4):248-52. PubMed ID: 18654945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck.
    Sung MW; Lee DW; Kim DY; Lee SJ; Hwang CH; Park SW; Kim KH
    Laryngoscope; 2001 Aug; 111(8):1430-3. PubMed ID: 11568580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.
    Peters DA; Courtemanche DJ; Heran MKS; Ludemann JP; Prendiville JS
    Plast Reconstr Surg; 2006 Nov; 118(6):1441-1446. PubMed ID: 17051116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymphatic malformations in the head and neck: experiences with sclerotherapy].
    Knipping S; Bau V
    HNO; 2011 Jul; 59(7):683-8. PubMed ID: 21509618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OK-432 therapy in 64 patients with lymphangioma.
    Ogita S; Tsuto T; Nakamura K; Deguchi E; Iwai N
    J Pediatr Surg; 1994 Jun; 29(6):784-5. PubMed ID: 8078021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbubbles in macrocysts - Contrast-enhanced ultrasound assisted sclerosant therapy of a congenital macrocystic lymphangioma: a case report.
    Menendez-Castro C; Zapke M; Fahlbusch F; von Goessel H; Rascher W; Jüngert J
    BMC Med Imaging; 2017 Jul; 17(1):39. PubMed ID: 28683719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.